Clinical Trial Update: Enoxolone in Major Depression - Biomarker-outcome Relationship [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial investigates enoxolone in major depressive disorder, focusing on biomarker–outcome relationships, and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Enoxolone (enoxolone)

Snippet

Sponsor: Philipps University Marburg | Conditions: Unipolar Depression | Phase 1, Phase 2 | Status: RECRUITING